S
Sphere Medical Holding
Patient-connected critical care blood gas monitoring systems
About Sphere Medical Holding
Sphere Medical Holding PLC was a medical device company that developed, manufactured, and sold monitoring products for critical care environments. Incorporated in 2001 and based in Cambridge, UK, the company focused on creating diagnostic equipment for the near-real-time measurement of blood gases, electrolytes, and metabolites. The company's operations ceased as of December 30, 2021.
The company's flagship product was the Proxima platform, a patient-dedicated blood gas analyser designed for use in intensive care units (ICU) and operating rooms. The system integrated directly into the patient's arterial line, providing rapid analysis at the bedside. This ex-vivo, closed-loop system drew a blood sample, analyzed it with a miniaturized sensor, and returned the blood to the patient, minimizing blood loss and infection risk. The Proxima system aimed to enable faster clinical decision-making and improve patient outcomes by providing continuous data without leaving the patient's side. Over its lifecycle, Sphere Medical launched successive generations of the product, including Proxima 3 and Proxima 4, with the latter expanding the analyte panel and adding usability for certain pediatric patients.
Sphere Medical operated through a direct sales force in the UK, Germany, the Netherlands, and Belgium, and utilized distributors in other markets like Italy and Spain. The company's business model was centered on the commercialization of its Proxima platform, generating revenue from the sale of the bedside monitors and disposable sensors. Despite securing CE Mark approval for its products and expanding its commercial reach into Europe, the company ultimately went out of business.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2011
- Open positions
- None listed
- Dealroom signal
- 29.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Testing, Biotechnology, Hard Tech, medical testing, DT and LS, uk is8 life sciences, science-based
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITY✓Other financing | Apr 2015 | $17M | — | Arthurian Life Sciences · Parkwalk Advisors | — |
| IPO✓Exit | Nov 2011 | $0 | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sphere Medical Holding is 100 monthly website visits, down 37.5% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sphere Medical Holding in the Cambridge ecosystem
The Sphere Medical Holding office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Artemis
Herald Ventures
Oxford Capital
Eight Roads Ventures
Series B and later2 investors entered at this stage
Arthurian Life Sciences
Parkwalk Advisors
Other known investors1 additional known investor
University of Bristol Enterprise Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sphere Medical Holding on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sphere Medical Holding’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









